| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-47178SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-90136SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54469-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-29619SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47909-0.1mg | |||
| IHC-Prediluted | NBP2-48362 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-83409-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-19788SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-31150SS | |||
| Azide and BSA Free | NBP2-80983 | |||
![Western Blot: HIF-1 alpha Antibody - Exon 9 [NBP1-47178] - Human recombinant HIF-1 alpha protein.](http://images.novusbio.com/fullsize/HIF-1-alpha-Exon-9-Antibody-exon-9-Western-Blot-NBP1-47178-img0002.jpg "Western Blot: HIF-1 alpha Antibody - Exon 9 [NBP1-47178] - Human recombinant HIF-1 alpha protein.")
![Western Blot: S100A12 Antibody [NB110-90136] - Detection of S100A12 in HeLa whole cell extracts.](http://images.novusbio.com/fullsize/S100A12-Antibody-Western-Blot-NB110-90136-img0003.jpg "Western Blot: S100A12 Antibody [NB110-90136] - Detection of S100A12 in HeLa whole cell extracts.")
![Immunocytochemistry/Immunofluorescence: S100A12 Antibody [NB110-90136] - S100A12 antibody was tested in HeLa cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/S100A12-Antibody-Immunocytochemistry-Immunofluorescence-NB110-90136-img0005.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody (NBP2-20866) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20866_rabbit-polyclonal-vitronectin-antibody-910202420104489.jpg)
![Western Blot: CD79A Antibody (IGA/1688R) [NBP2-53138] - Western Blot Analysis of human Raji cell lysate using CD79A Antibody (IGA/1688R).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1688R-Western-Blot-NBP2-53138-img0003.jpg "Western Blot: CD79A Antibody (IGA/1688R) [NBP2-53138] - Western Blot Analysis of human Raji cell lysate using CD79A Antibody (IGA/1688R).")
![Immunocytochemistry/Immunofluorescence: CD79A Antibody (IGA/1688R) [NBP2-53138] - Immunofluorescence Analysis of PFA-fixed Raji cells labeling CD79a with followed by Goat anti-rabbit IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1688R-Immunocytochemistry-Immunofluorescence-NBP2-53138-img0002.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (IGA/1688R) [NBP2-53138] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD79a Recombinant Rabbit Monoclonal Antibody (IGA/1688R).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1688R-Immunohistochemistry-Paraffin-NBP2-53138-img0001.jpg)
![Flow Cytometry: CD79A Antibody (IGA/1688R) [NBP2-53138] - Flow Cytometric Analysis of Raji cells using CD79A Antibody (IGA/1688R) followed by Goat anti-rabbit IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1688R-Flow-Cytometry-NBP2-53138-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: Plastin L Antibody [NBP2-19860] - Plastin L antibody detects Plastin L protein by immunofluorescent analysis. Sample: A549 cells were fixed in ice-cold MeOH for 5 min. Green: Plastin Lstained by Plastin L antibody diluted at 1:500. Blue: Hoechst 33342 staining. Scale bar= 10 um.](http://images.novusbio.com/fullsize/Plastin-L-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-19860-img0007.jpg "Immunocytochemistry/Immunofluorescence: Plastin L Antibody [NBP2-19860] - Plastin L antibody detects Plastin L protein by immunofluorescent analysis. Sample: A549 cells were fixed in ice-cold MeOH for 5 min. Green: Plastin Lstained by Plastin L antibody diluted at 1:500. Blue: Hoechst 33342 staining. Scale bar= 10 um.")
![Western Blot: Plastin L Antibody [NBP2-19860] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Plastin L antibody diluted at 1:10000. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Plastin-L-Antibody-Western-Blot-NBP2-19860-img0008.jpg)
![Immunohistochemistry-Paraffin: Plastin L Antibody [NBP2-19860] - Plastin L antibody detects Plastin L protein at cell membrane by immunohistochemical analysis.Sample: Paraffin-embedded mouse thymus gland.Plastin L stained by Plastin L antibody (NBP2-19860) diluted at 1:500.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/nbp2-19860_rabbit-polyclonal-plastin-l-antibody-91020242063320.jpg)
![Immunocytochemistry/Immunofluorescence: Optineurin Antibody [NBP1-84683] - Immunofluorescent staining of human cell line A-431 shows localization to cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Optineurin-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-84683-img0007.jpg "Immunocytochemistry/Immunofluorescence: Optineurin Antibody [NBP1-84683] - Immunofluorescent staining of human cell line A-431 shows localization to cytosol. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: Optineurin Antibody [NBP1-84683] - Staining of human cerebral cortex shows moderate cytoplasmic positivity in neuronal cells.](http://images.novusbio.com/fullsize/Optineurin-Antibody-Immunohistochemistry-Paraffin-NBP1-84683-img0012.jpg)
![Immunohistochemistry-Paraffin: Optineurin Antibody [NBP1-84683] - Staining of human kidney shows weak cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/Optineurin-Antibody-Immunohistochemistry-Paraffin-NBP1-84683-img0013.jpg)
![Immunohistochemistry-Paraffin: Optineurin Antibody [NBP1-84683] - Staining of human rectum shows moderate cytoplasmic positivity in cells in granular layer.](http://images.novusbio.com/fullsize/Optineurin-Antibody-Immunohistochemistry-Paraffin-NBP1-84683-img0014.jpg)
![Immunohistochemistry-Paraffin: Optineurin Antibody [NBP1-84683] - Staining of human testis shows moderate cytoplasmic positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/Optineurin-Antibody-Immunohistochemistry-Paraffin-NBP1-84683-img0015.jpg)
![Western Blot: Siglec-3/CD33 Antibody [NBP2-29619] - Analysis of CD33 in the partial recombinant protein.](http://images.novusbio.com/fullsize/CD33-Antibody-Western-Blot-NBP2-29619-img0001.jpg "Western Blot: Siglec-3/CD33 Antibody [NBP2-29619] - Analysis of CD33 in the partial recombinant protein.")
![Immunohistochemistry-Paraffin: Siglec-3/CD33 Antibody [NBP2-29619] - Analysis of CD33 protein in a section of human small intestinal malignant stromal tumor using 5 ug/mL concentration of CD33 antibody. The cancer cells developed the expected membrane-cytoplasmic staining pattern.](http://images.novusbio.com/fullsize/CD33-Antibody-Immunohistochemistry-Paraffin-NBP2-29619-img0002.jpg)
![In vitro assay: TNFSF4 Protein [NBP2-26577] - Demonstration in vitro of the potency of Fc-OX40L in comparison to an agonist antibody OX86, with anti-CD3 alone serving as a negative control for co-stimulation.](http://images.novusbio.com/fullsize/TNFSF4-Protein-In-vitro-assay-NBP2-26577-img0001.jpg "In vitro assay: TNFSF4 Protein [NBP2-26577] - Demonstration in vitro of the potency of Fc-OX40L in comparison to an agonist antibody OX86, with anti-CD3 alone serving as a negative control for co-stimulation.")
![SDS-Page: TNFSF4 Protein [NBP2-26577] - Electrophoretic analysis of Fc-mOX40L using Coomassie blue stained 4-20% reducing SDS-PAGE.](http://images.novusbio.com/fullsize/TNFSF4-Protein-SDS-Page-NBP2-26577-img0002.jpg)
![SDS-Page: Recombinant Mouse OX40 Ligand/TNFSF4 Protein [NBP2-26577] - Electrophoretic analysis of Fc-mOX40L using Coomassie blue stained 4-15% reducing SDS-PAGE.](http://images.novusbio.com/fullsize/Recombinant-Mouse-OX40-Ligand-TNFSF4-Protein-SDS-Page-NBP2-26577-img0004.jpg)
![Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-NBP2-44567-img0005.jpg "Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Angiosarcoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0001.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Colon Carcinoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0002.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Placenta stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0003.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Tonsil stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0004.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0006.jpg "Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.")
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human kidney shows moderate to strong granular cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0004.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human gallbladder shows moderate to strong granular cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0005.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human tonsil shows very weak positivity as expected.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: beta-1,3-Glucuronyltransferase 1/B3GAT1 Antibody [NBP1-19788] - Antibody was tested in U2OS cells with FITC (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/beta-1-3-Glucuronyltransferase-1-B3GAT1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-19788-img0005.jpg "Immunocytochemistry/Immunofluorescence: beta-1,3-Glucuronyltransferase 1/B3GAT1 Antibody [NBP1-19788] - Antibody was tested in U2OS cells with FITC (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).")
![Immunohistochemistry: beta-1,3-Glucuronyltransferase 1/B3GAT1 Antibody [NBP1-19788] - Analysis in mouse brain using DAB with hematoxylin counterstain.](http://images.novusbio.com/fullsize/beta-1-3-Glucuronyltransferase-1-B3GAT1-Antibody-Immunohistochemistry-NBP1-19788-img0006.jpg)
![Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Mouse Liver (lane 1), Mouse Kidney (lane 2) and Mouse Spleen (lane 3) were separated by SDS-PAGE and the protein transferred to PVDF. The membrane was then probed with anti-TLR9 at 2ug/mL and detected with an anti-rat HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Western-Blot-NBP2-31150-img0007.jpg "Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Mouse Liver (lane 1), Mouse Kidney (lane 2) and Mouse Spleen (lane 3) were separated by SDS-PAGE and the protein transferred to PVDF. The membrane was then probed with anti-TLR9 at 2ug/mL and detected with an anti-rat HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Analysis of TLR9 protein in normal mouse epididymis section using TLR9 antibody (clone 2E5) at a concentration of 5 ug/mL. This antibody developed strong cytoplasmic staining in the pseudostratified columnar epithelial cells as well as the blood vessels of epididymis. The basal cells, the smooth muscle cells and the mature sperm cells were largely found negative for TLR9 staining.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Immunohistochemistry-Paraffin-NBP2-31150-img0006.jpg)
![Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - TLR9 Antibody (2E5) [NBP2-31150] - TLR9 Antibody (2E5) [NBP2-31150] - WB analysis of partial recombinant TLR9 protein (expected molecular weight ~21kDa) with TLR9 antibody (clone 2A4C6.2E5) at a concentration of 2 ug/mL.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Western-Blot-NBP2-31150-img0004.jpg)